Summary
The significance of pre-operative transcatheter arterial chemoembolization therapy using lipiodol, cisplatin and gelatin sponge (Gelfoam) for the prevention of the recurrence of hepatocellular carcinoma (HCC) was evaluated. On the 103 patients who underwent radical operations for HCC with a tumor size less than 10 cm, 52 patients received no pre-operative therapy (group C), and 51 patients received pre-operative chemoembolization using lipiodol, a chemotherapeutic agent and Gelfoam. Of these 51 patients, 37 patients received a combination of lipiodol, cisplatin and Gelfoam (group A), while the remaining 14 patients received lipiodol, adriamycin and Gelfoam (group B). The disease-free survival rates after surgery were compared between group A, group B and group C. The 2-year disease-free survival rates in group A, group B and group C were 72%, 46% and 54%, respectively. These rates therefore suggest that pre-operative chemoembolization using lipiodol, cisplatin and Gelfoam is a useful method to prevent the recurrence of HCC after surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K (1984) Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199: 51
Lee CS, Sung JL, Hwang LY, Sheu JC, Chen DA, Lin TY, Beasley RP (1986) Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery 99: 481
The Liver Cancer Study Group of Japan (1984) Primary liver cancer of Japan. Cancer 54: 1747
Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161: 346
Nagasue N, Yukawa H, Ogawa Y, Sasaki Y, Chang YC, Niimi K (1986) Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 99: 694
Nakamura K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, Yokoyama I (1983) Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 52: 2193
Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, Matsuo N, Hosogi Y (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154: 25
Okamoto E, Tanaka N, Yamanaka N, Toyosaka A (1984) Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg 8: 360
Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemoembolization effective for treating hepatocellular carcinoma a histopathologic study. Cancer 54: 387
Sasaki Y, Imaoka S, Matsui Y, Ishikawa O, Taniguchi K, Iwanaga T, Terasawa T, Okawa T, Ishiguro S, Hori S (1982) Evaluation of preoperative transcatheter arterial embolization for hepatic carcinoma. J Jpn Soc Cancer Ther 17: 1917
Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H, Koyama H, Iwanaga T (1987) A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60: 1194
Sheu JC, Lee CS, Sung JL, Chen DS, Yang PM, Lin TY (1985) Intraoperative hepatic ultrasonography — An indispensable procedure in resection of small hepatocellular carcinoma. Surgery 97: 97
Tsuzuki T, Ogata Y, Iida S, Shimazu M (1984) Hepatic resection in 125 patients. Arch Surg 119: 1025
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imaoka, S., Sasaki, Y., Shibata, T. et al. A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 23 (Suppl 1), S126–S128 (1989). https://doi.org/10.1007/BF00647258
Issue Date:
DOI: https://doi.org/10.1007/BF00647258